Further investigation of the mechanism and function of SPON1-TRIM29 fusion protein, including additional cell lines and primary cells, will provide useful information for the development of new therapeutic options for ovarian cancer with the aberrant molecule expression. Here, TRIM29 is linked to ovarian cancer.